{"disease":{"id":"ebv-lymphomas","name":"ebv lymphomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04902443","title":"Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02388490","title":"Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Seoul National University Hospital","has_results":true},{"nct_id":"NCT05882305","title":"KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Kousai Bio Co., Ltd.","has_results":false},{"nct_id":"NCT03988582","title":"Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}